We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/9/2019 21:37 | Probably a good shout there someuwin. Excellent news if Miton are out as their Microcap Trust recently delayed redemptions while they try to liquidate illiquid holdings (Woodford type issues). Means they are no longer supporting companies, quite the opposite. Let’s hope the overhang has gone. | bones | |
02/9/2019 21:01 | The last late reported trade today was a sell of 167,071 (£74,346 worth) According to the Aortech website, Miton was holding 862,071 shares (5.87%) at 16 April 2019. 862,071 - 167,071 = 695,000 So my guess is that Miton have been selling round number blocks of shares (50k, 100k etc) over the past months and today dumped the last remnants. Hopefully get an RNS to confirm soon. | someuwin | |
02/9/2019 14:19 | Net, looks to me like the Miton overhang might have cleared? Once there is a jump in price of a stock with no liquidity, the buyers pile in. It may fall back a bit I guess while we wait on updates. | bones | |
02/9/2019 13:49 | why the sudden big jump? I know its fallen loads but wasn't really expecting it to jump back up, normally, with many stocks, rises back up are more casual. Is there a reason for this steep rise? Thanks | netcurtains | |
02/9/2019 11:37 | Nice to see some movement in the good direction lol | herschel k | |
02/9/2019 11:00 | Good news if so, they were a pain in the rear! | bones | |
02/9/2019 10:51 | I managed to get another 10 at below mid. From what I can gather Cantors were the big seller so, if they are now on the bid, that should augur well for overhang gone. | langland | |
02/9/2019 10:48 | Wouldn't let me buy many. | someuwin | |
02/9/2019 10:41 | Well played, langland! Another bunch of 50k’s through at below mid, suggests MITON cleaning out for good? If not, then who knows? The market makers are standing pat. EDIT: Cantors now strongly on the bid at 47p | bones | |
02/9/2019 10:11 | Possibly. Though I think they could all be buys this AM. I have bought 36.2 so far. | langland | |
02/9/2019 10:08 | A little bit of liquidity showing up. I will wager that the 50k is another slug of MITON heading out the door. Once they have gone, we may be in business? | bones | |
29/8/2019 12:16 | Good to see common sense buying. Shares have drifted since board confirmed this was not an overnight investment but all looks good to me. Newsflow due re new licensing opportunities and then updates on the two key projects, with GELS in the background. Given current fears surrounding textured implants, what a position Aortech are in. Just need to keep the faith.. | greedy rooster | |
23/8/2019 13:01 | Is that Miton unloading again? 50,000 @ 43p | bones | |
23/8/2019 13:01 | I've responded langland. | bones | |
23/8/2019 12:52 | BTW, bones, I sent you a PM earlier. | langland | |
23/8/2019 12:41 | Thanks Landy90, there is gold in them thar hills, or at least hope of it! Pass me a shovel. | bones | |
23/8/2019 12:39 | Only the $1.4bn eh? Cheapskates. | langland | |
23/8/2019 12:27 | I try to keep my ear to the ground on what is going on at Foldax. I understand that the first implant (early feasibility study of 15 valves) took place in early August with another 9 due over the rest of the month. The first implant went well. Foldax are in discussions with Goldman Sachs who are placing a $1.4 billion valuation on the business. None of the above seems unreasonable and I can understand Bill Brown's frustration with our current valuation. The Foldax valuation if true gives a good read through on what the AorTech valve should be worth in a year or two. | landy90 | |
23/8/2019 12:06 | Someuwin, I understand that Shore Capital is putting the story about the investment scene but I guess July/August during a soggy, fear-paralysed economic environment is not conducive to making sales! | bones | |
23/8/2019 11:30 | Thanks bones - all very useful stuff. I'd still like them to do a presentation somewhere to spread the story. | someuwin | |
23/8/2019 11:29 | Thanks for the update Bones. | semper vigilans | |
23/8/2019 11:19 | Someuwin, I said to Bill that I took “current year” to mean the year ended 31 March 2020 in that paragraph of his and I was not contradicted. No specifics on dates but, for example, the cleanroom at RUA Medical will be completed for prototype production at some stage soon I imagine, as David Richmond mentioned that the floor was in! Other milestones probably will relate to heart valve IT developments by VFT. All of that side is in the name of getting the regulatory paperwork in line. It is accepted these days by the FDA that computer modelling using today’s tools is a key factor in their deliberations about whether some device might work in the body. | bones | |
23/8/2019 11:14 | Cheers bones. Good AGM report. Have you got any info (or opinion) on what the "expectations of the timelines" are? | someuwin | |
23/8/2019 11:05 | Indeed. All other things being equal, I see this from a chart pov. 40p is a key territory, as you can see from the two year chart. It went, basically, from 20-40-80p, and then back to 40. I have read of no bad news, and as you keep us informed, I cannot imagine that the story will not continue to develop positively. So it simply remains a question of what price investors are willing to pay for the prospective reward. | brucie5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions